SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
AMEV-Applied Molecular Evolution
An SI Board Since January 2001
Posts SubjectMarks Bans Symbol
164 16 0 AMEV
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
139That was among the longest "background to merger" I've seen. I&#rkrw-12/24/2003
138great stuff, thanks for thinking of us. Rickscaram(o)uche-12/24/2003
137Always my favorite read from mergers docs... THE MERGER Background of the Merrkrw-12/24/2003
136Press Release Source: MedImmune, Inc. MedImmune to Study Therapeutic Benefit orkrw-12/17/2003
135Lilly to acquire Applied Molecular for $400 mln NEW YORK, Nov 21 (Reuters) - ElVIXandMore-11/21/2003
134Looks like they picked a very well connected lead investigator. Kavanaugh is verrkrw-11/18/2003
133Thanks for the correction. I guess I need to do more HW :-) I'd think humirkrw-11/18/2003
132rkrw, peter, remicade- - requires mtx, for ra enbrel - - does not require mtx;software salesperson-11/18/2003
131<i>All of the anti-tnf's: remicade, enbrel, humira are used in combo wBiomaven-11/18/2003
130<<mtx is not being used with this new therapy?<< Sales, Good questrkrw-11/18/2003
129rkrw, mtx is not being used with this new therapy? thanks. salessoftware salesperson-11/18/2003
128And the PR... Press Release Source: Applied Molecular Evolution, Inc. Appliedrkrw-11/18/2003
127Applied Molecular to test its version of Remicade Tuesday November 18, 12:01 am scaram(o)uche-11/18/2003
126>>SAN DIEGO, Nov. 6 /PRNewswire-FirstCall/ -- Applied Molecular Evolution,tuck-11/7/2003
125AMEV beats by a couple of pennies, for what that's worth, and adds a little tuck-11/4/2003
124Nice mention in The Wall Street Transcript (interview with David E. Wood, SeniorVIXandMore-10/31/2003
123AMEV breaking out once again Nice technical move to 12.85. I wonder how much oVIXandMore-10/31/2003
122<<Has Maxygen been seen as a significant competitor in antibody optimisatirkrw-10/28/2003
121<i>should bode well for amev</i> Has Maxygen been seen as a signifinigel bates-10/28/2003
120Lundbeck gives it back and the stock is up $.12?keokalani'nui-10/28/2003
119This should bode well for amev: <<Separately, Maxygen announced that, asrkrw-10/28/2003
118Applied Molecular Evolution Achieves Milestone in Collaboration with Centocor Tunigel bates-10/21/2003
117<i>This is very bullish for AMEV, I do believe.</i> Diversa and Medkeokalani'nui-10/16/2003
116Novasite Pharmaceuticals Awarded NIH Grants for the Discovery and Optimization onigel bates-10/15/2003
115From Briefing.com: >>9:40AM Applied Molecular target raised to $13 at Rodtuck-10/8/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News